Helga Rübsamen-Schaeff

Helga Rübsamen-Schaeff is the founder of AiCuris GmbH & Co. KG, founded in 2006, where the title held was Managing Director from 2006 to 2015.
Dr. Rübsamen-Schaeff is the founder of Aicuris Anti-Infective Cures AG, founded in 2006, holding the title Member-Supervisory Board currently.
Current jobs include Chairman-Supervisory Board at Merck Healthcare KGaA; Member-Supervisory Board at Merck KGaA since 2014; Member-Supervisory Board at 4SC AG since 2015; Professor at Johann Wolfgang Goethe-Universität Frankfurt am Main since 1988; Member-Supervisory Board at Universitätsklinikum Bonn; Partner at E.
Merck KG; Member at Deutsche Akademie der Naturforscher Leopoldina eV; Member-Supervisory Board at Merck Life Science KGaA; and Member at Deutsche Akademie der Technikwissenschaften eV since 2022.
Former jobs include Scientific & Executive Director at Chemotherapeutic Research Institute Georg-Speyer-Haus from 1987 to 1993; Managing Director at Georg Speyer Haus from 1987 to 1993; SVP & Global Head-Anti Infective Research at Bayer HealthCare AG from 2001 to 2006; and Senior VP & Head-Antiinfectives Research at Bayer AG from 2001 to 2006.
Education includes an undergraduate degree conferred in 1971 and a doctorate conferred in 1973, both from the University of Münster.